161 related articles for article (PubMed ID: 34867446)
21. miR-146b-5p activation of hepatic stellate cells contributes to the progression of fibrosis by directly targeting HIPK1.
Xie J; Cheng N; Huang Z; Shu X; Xiang T
Exp Ther Med; 2022 Aug; 24(2):537. PubMed ID: 35837064
[TBL] [Abstract][Full Text] [Related]
22. miR-139-5p sponged by LncRNA NEAT1 regulates liver fibrosis via targeting β-catenin/SOX9/TGF-β1 pathway.
Wang Q; Wei S; Li L; Bu Q; Zhou H; Su W; Liu Z; Wang M; Lu L
Cell Death Discov; 2021 Sep; 7(1):243. PubMed ID: 34531378
[TBL] [Abstract][Full Text] [Related]
23. miR-582-5p is upregulated in patients with active tuberculosis and inhibits apoptosis of monocytes by targeting FOXO1.
Liu Y; Jiang J; Wang X; Zhai F; Cheng X
PLoS One; 2013; 8(10):e78381. PubMed ID: 24205217
[TBL] [Abstract][Full Text] [Related]
24. miR-193a/b-3p relieves hepatic fibrosis and restrains proliferation and activation of hepatic stellate cells.
Ju B; Nie Y; Yang X; Wang X; Li F; Wang M; Wang C; Zhang H
J Cell Mol Med; 2019 Jun; 23(6):3824-3832. PubMed ID: 30945448
[TBL] [Abstract][Full Text] [Related]
25. MiR-873-5p acts as an epigenetic regulator in early stages of liver fibrosis and cirrhosis.
Fernández-Ramos D; Fernández-Tussy P; Lopitz-Otsoa F; Gutiérrez-de-Juan V; Navasa N; Barbier-Torres L; Zubiete-Franco I; Simón J; Fernández AF; Arbelaiz A; Aransay AM; Lavín JL; Beraza N; Perugorria MJ; Banales JM; Villa E; Fraga MF; Anguita J; Avila MA; Berasain C; Iruzibieta P; Crespo J; Lu SC; Varela-Rey M; Mato JM; Delgado TC; Martínez-Chantar ML
Cell Death Dis; 2018 Sep; 9(10):958. PubMed ID: 30237481
[TBL] [Abstract][Full Text] [Related]
26. miR-144 regulates transforming growth factor-β1 iduced hepatic stellate cell activation in human fibrotic liver.
Liu Z; Yi J; Ye R; Liu J; Duan Q; Xiao J; Liu F
Int J Clin Exp Pathol; 2015; 8(4):3994-4000. PubMed ID: 26097586
[TBL] [Abstract][Full Text] [Related]
27. miR-29a-3p suppresses hepatic fibrosis pathogenesis by modulating hepatic stellate cell proliferation via targeting PIK3R3 gene expression.
Fu J; Wu B; Zhong S; Deng W; Lin F
Biochem Biophys Res Commun; 2020 Sep; 529(4):922-929. PubMed ID: 32819600
[TBL] [Abstract][Full Text] [Related]
28. miR-455-3p Alleviates Hepatic Stellate Cell Activation and Liver Fibrosis by Suppressing HSF1 Expression.
Wei S; Wang Q; Zhou H; Qiu J; Li C; Shi C; Zhou S; Liu R; Lu L
Mol Ther Nucleic Acids; 2019 Jun; 16():758-769. PubMed ID: 31150929
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of miR-182-5p attenuates pulmonary fibrosis via TGF-β/Smad pathway.
Chen Y; Zhang Q; Zhou Y; Yang Z; Tan M
Hum Exp Toxicol; 2020 May; 39(5):683-695. PubMed ID: 31884830
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-98 Inhibits Hepatic Stellate Cell Activation and Attenuates Liver Fibrosis by Regulating HLF Expression.
Wang Q; Wei S; Zhou H; Li L; Zhou S; Shi C; Shi Y; Qiu J; Lu L
Front Cell Dev Biol; 2020; 8():513. PubMed ID: 32637414
[TBL] [Abstract][Full Text] [Related]
31. Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition.
Chen Y; Ou Y; Dong J; Yang G; Zeng Z; Liu Y; Liu B; Li W; He X; Lan T
Exp Cell Res; 2018 Jan; 362(2):343-348. PubMed ID: 29196165
[TBL] [Abstract][Full Text] [Related]
32. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation.
Qu Y; Zhang Q; Cai X; Li F; Ma Z; Xu M; Lu L
J Cell Mol Med; 2017 Oct; 21(10):2491-2502. PubMed ID: 28382720
[TBL] [Abstract][Full Text] [Related]
33. The anti-fibrotic effects of epigallocatechin-3-gallate in bile duct-ligated cholestatic rats and human hepatic stellate LX-2 cells are mediated by the PI3K/Akt/Smad pathway.
Yu DK; Zhang CX; Zhao SS; Zhang SH; Zhang H; Cai SY; Shao RG; He HW
Acta Pharmacol Sin; 2015 Apr; 36(4):473-82. PubMed ID: 25832428
[TBL] [Abstract][Full Text] [Related]
34. Physalin D attenuates hepatic stellate cell activation and liver fibrosis by blocking TGF-β/Smad and YAP signaling.
Xiang D; Zou J; Zhu X; Chen X; Luo J; Kong L; Zhang H
Phytomedicine; 2020 Nov; 78():153294. PubMed ID: 32771890
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of LncRNA FOXD3-AS1 suppresses the aggressive biological behaviors of thyroid cancer via elevating miR-296-5p and inactivating TGF-β1/Smads signaling pathway.
Chen Y; Gao H; Li Y
Mol Cell Endocrinol; 2020 Jan; 500():110634. PubMed ID: 31678422
[TBL] [Abstract][Full Text] [Related]
36. Dual Targeting of Angipoietin-1 and von Willebrand Factor by microRNA-671-5p Attenuates Liver Angiogenesis and Fibrosis.
Yang L; Yue W; Zhang H; Zhang Z; Xue R; Dong C; Liu F; Chang N; Yang L; Li L
Hepatol Commun; 2022 Jun; 6(6):1425-1442. PubMed ID: 35014213
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-140-5p Mediates Renal Fibrosis Through TGF-β1/Smad Signaling Pathway by Directly Targeting TGFBR1.
Liao W; Liang P; Liu B; Xu Z; Zhang L; Feng M; Tang Y; Xu A
Front Physiol; 2020; 11():1093. PubMed ID: 33013464
[TBL] [Abstract][Full Text] [Related]
38. Human Liver Stem Cell-Derived Extracellular Vesicles Target Hepatic Stellate Cells and Attenuate Their Pro-fibrotic Phenotype.
Chiabotto G; Ceccotti E; Tapparo M; Camussi G; Bruno S
Front Cell Dev Biol; 2021; 9():777462. PubMed ID: 34796180
[TBL] [Abstract][Full Text] [Related]
39. MicroRNA-146a-5p attenuates liver fibrosis by suppressing profibrogenic effects of TGFβ1 and lipopolysaccharide.
Zou Y; Cai Y; Lu D; Zhou Y; Yao Q; Zhang S
Cell Signal; 2017 Nov; 39():1-8. PubMed ID: 28739486
[TBL] [Abstract][Full Text] [Related]
40. MiR-448-5p inhibits TGF-β1-induced epithelial-mesenchymal transition and pulmonary fibrosis by targeting Six1 in asthma.
Yang ZC; Qu ZH; Yi MJ; Shan YC; Ran N; Xu L; Liu XJ
J Cell Physiol; 2019 Jun; 234(6):8804-8814. PubMed ID: 30362537
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
